Wakano Ogawa

1.3k citations
41 papers · 1.1k indexed · h-index 22
Topics
Antibiotic Resistance in Bacteria (24 papers)Bacterial Genetics and Biotechnology (11 papers)Vibrio bacteria research studies (8 papers)
Partner nations
JapanNew ZealandCzechia

In The Last Decade

Wakano Ogawa

41 papers receiving 1.0k citations

Peers

Wakano Ogawa
Comparison fields: 5 of 84
  • Molecular Medicine 506
  • Molecular Biology 419
  • Endocrinology 220
  • Genetics 176
  • Pharmacology 169
Replace Nick G. Coldham with:
Nick G. Coldham United Kingdom
Chien‐Fang Peng Taiwan
Yongxin Jin China
Sandrine Alibert France
Jorge L. Galazzo United States
Maarten Vercruysse United States
Zhiqiang Yang China
Yun Kang United States
Marcus Ho Yin Wong Hong Kong
Shu-Huei Tsai Taiwan
Wakano Ogawa relative to Nick G. Coldham United Kingdom Nick G. Coldham's profile →
Citations per field
00.5×2.6×
Nick G. Coldham · 1×
Citations per year

Countries citing papers authored by Wakano Ogawa

Since Specialization
Citations

This map shows the geographic impact of Wakano Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wakano Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wakano Ogawa more than expected).

Fields of papers citing papers by Wakano Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wakano Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wakano Ogawa. The network helps show where Wakano Ogawa may publish in the future.

Co-authorship network of co-authors of Wakano Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Wakano Ogawa. A scholar is included among the top collaborators of Wakano Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wakano Ogawa. Wakano Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 54
3 15
4 2
5 21
6 19
7 18
8 10
9 5
10 13
11 63
12 20
13 57
14 44
15 28
16 29
17 11
18 8
19 20
20 2

About Wakano Ogawa

Wakano Ogawa is a scholar working on Molecular Medicine, Endocrinology and Toxicology, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (24 papers), Bacterial Genetics and Biotechnology (11 papers) and Vibrio bacteria research studies (8 papers). The work is most often cited by research in Molecular Medicine (506 citations), Endocrinology (220 citations) and Pharmacology (169 citations). Wakano Ogawa has collaborated with scholars based in Japan, New Zealand and Czechia. Frequent co-authors include Tomofusa Tsuchiya, Teruo Kuroda, Tohru Mizushima, Motoyasu Onishi, Yusuke Minato, Nao Otsuka, Tsutomu Hatano, Sumiko Shiota, Anowara Begum and Kenji Sasaki. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026